سال 13، شماره 1 - ( فروردین - اردیهبشت 1398 )                   جلد 13 شماره 1 صفحات 13-1 | برگشت به فهرست نسخه ها


XML English Abstract Print


1- گروه علوم و صنایع غذایی، دانشکده صنایع غذایی، دانشگاه علوم کشاورزی و منابع طبیعی گرگان، گرگان، ایران
2- گروه علوم و صنایع غذایی، دانشکده صنایع غذایی، دانشگاه علوم کشاورزی و منابع طبیعی گرگان، گرگان، ایران ، khomeiri@gau.ac.ir
چکیده:   (8405 مشاهده)
 در گذشته مردم برای بهبود سلامتی و یا درمان برخی از بیماری‌ها از ‌مواد غذایی تخمیری که حاوی باکتری‌های پروبیوتیک هستند، استفاد می‌کردند. امروزه نیز خواص درمانگری پروبیوتیک‌ها بیش از پیش بر همگان آشکار است؛ تا جایی که در سال‌های اخیر توجه بسیاری به ارتباطات بالقوه بین میکروب‌های روده و سلامت روان معطوف شده است. نتایج مطالعات متعدد نشان می‌دهد میکروب‌های روده از طریق تولید مولکول‌های فعال عصبی در توسعه و عملکرد مغز و همچنین متغیرهای اعصاب و روان مانند خواب، اشتها، خلق و خوی و ادراک نقش دارند. این یافته‌ها به نوبه خود باعث شده است تحقیقات بیشتری در زمینه راه‌های درمانی جدید برای رفع اختلالات روانی از طریق تغییر و اصلاح فلور میکروبی روده با استفاده از یک گروه درمانی جدید تحت عنوان سایکوبیوتیک‌ها انجام شود. سایکوبیوتیک‌ها باکتری‌های پروبیوتیکی هستند که اگر در دوزهای کافی مصرف شوند، بر عملکرد روده و مغز تأثیر می‌گذارند و باعث بهبود علائم مربوط به بیماری‌های اعصاب و روان می‎شوند.
متن کامل [PDF 832 kb]   (3703 دریافت) |   |   متن کامل (HTML)  (19064 مشاهده)  
نوع مطالعه: مقاله مروری | موضوع مقاله: میکروب شناسی مواد غذایی
دریافت: 1397/10/25 | پذیرش: 1398/3/12 | انتشار الکترونیک: 1398/4/29

فهرست منابع
1. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C. et al. A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nat. 2010; 464(7285): 59-65. [DOI:10.1038/nature08821] [PMID] [PMCID]
2. Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Gut Microbiota Controls Adipose Tissue Expansion, Gut Barrier And Glucose Metabolism: Novel Insights Into Molecular Targets And Interventions Using Prebiotics. Benef Microbes. 2013; 1-15. [DOI:10.3920/BM2012.0065] [PMID]
3. Chen X, D'souza R, Hong ST. The Role of Gut Microbiota in the Gut-Brain Axis: Current Challenges and Perspectives. Protein Cell. 2013; 4: 403-14. [DOI:10.1007/s13238-013-3017-x] [PMID] [PMCID]
4. Ostaff MJ, Stange EF, Wehkamp J. Antimicrobial Peptides and Gut Microbiota in Homeostasis and Pathology. EMBO Mol Med. 2013; 5: 1465-1483. [DOI:10.1002/emmm.201201773] [PMID] [PMCID]
5. Honda K, Littman DR. The Microbiota in Adaptive Immune Homeostasis and Disease. Nat. 2016; 535: 75-84. [DOI:10.1038/nature18848] [PMID]
6. Penders J, Thijs C, Vink C. Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy. Pediatrics. 2016; 118(2): 511-521. [DOI:10.1542/peds.2005-2824] [PMID]
7. Yatsunenko T, Rey FE, Manary MJ. Human Gut Microbiome Viewed Across Age and Geography. Nat. 2012; 486(7402):222-227. [DOI:10.1038/nature11053] [PMID] [PMCID]
8. Dinan TG, Cryan FJ. Brain-Gut-Microbiota Axis and Mental Health. Int J Behav Med. 2017; 79(8): 920-926. [DOI:10.1097/PSY.0000000000000519] [PMID]
9. Grenham S, Clarke G,. Cryan J F, Dinan T G. Brain- Gut-Microbe Communication in Health And Disease. Front Physiol. 2011. [DOI:10.3389/fphys.2011.00094] [PMID] [PMCID]
10. Kali A. Human Microbiome Engineering: The Future and Beyond. J Clin Diagn Res. 2015; 9(9). [DOI:10.7860/JCDR/2015/14946.6570] [PMID] [PMCID]
11. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. Aminobutyric Acid Production by Culturable Bacteria From the Human Intestine. J of Appl Microbiol. 2012; 113: 411-7. [DOI:10.1111/j.1365-2672.2012.05344.x] [PMID]
12. Dicks LMT. Botes M. Probiotic Lactic Acid Bacteria in the Gastro Intestinal Tract: Health Benefits, Safety and Mode of Action. Benef Microbes. 2010; 1(1): 11-29. [DOI:10.3920/BM2009.0012] [PMID]
13. O'Mahony SM, Clarke G, Borre YE, Dinan T, Cryan JF. Serotonin, Tryptophan Metabolism and the Brain-Gut-Microbiome Axis. Behav Brain Res. 2014; 277:32-48. [DOI:10.1016/j.bbr.2014.07.027] [PMID]
14. Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. 2014; 817, 221-239. [DOI:10.1007/978-1-4939-0897-4_10] [PMID]
15. Dinan TG, Cryan FJ. Mood by Microbe: Towards Clinical Translation. Genome Med. 2013; 8:36. [DOI:10.1186/s13073-016-0292-1] [PMID] [PMCID]
16. Shahdadi F, Mirzaei H, Kashaninejad M, Khomeiri M, Ziaiifar AM, Akbarian A. Survival of Probiotics Encapsulated in Calcium Alginate and Resistant Starch Beads in Drinking Yoghurt Produced With Essential Oils During Storage and in Simulated Gastrointestinal Juice Conditions. Int J Biosci. 2014; 5(12): 58-71. [DOI:10.12692/ijb/5.12.58-71]
17. Vosough S, Khomeiri M, Kashaninejad M, Jafari M. Effect of Peppermint on Survival of Probiotic Bacteria in Iranian Traditional Beverage. J Agr Sci Nat Res. 2000; 16(1): 156-164.
18. Mokhtari S, Jafari M, Khomeiri M, Ghorbani M, Maghsoudlou M. The Cell Wall Compound of Saccharomyces Cerevisiae as a Novel Wall Material for Encapsulation of Probiotics. Food Res Int. 2017. [DOI:10.1016/j.foodres.2016.09.026]
19. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert Consensus Document: The International Scientific Association for Probiotics and Prebiotics Consensus Statement on the Scope and Appropriate Use of the Term Probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11: 506-514. [DOI:10.1038/nrgastro.2014.66] [PMID]
20. Petschow B, Dore J, Hibberd P, Dinan T, Reid G, Blaser M. Probiotics, Prebiotics, and the Host Microbiome: The Science of Translation. Ann N Y Acad Sci. 2013; 1306: 1-17. [DOI:10.1111/nyas.12303] [PMID] [PMCID]
21. Tsilingiri K, Rescigno M. Postbiotics: What else? Benef Microbes. 2013;4(1):101-7. [DOI:10.3920/BM2012.0046] [PMID]
22. Schrezenmeir J, de Vrese M. Probiotics, Prebiotics, and Synbiotics-Approaching a Definition. Am J Clin Nutr. 2001; 73, 361-364. [DOI:10.1093/ajcn/73.2.361s]
23. Rezaei R, Khomeiri M, Aalami M, Kashaninejad M. Steady and Dynamic Rheological Behaviour of Frozen Soy Yogurt Mix Affected by Resistant Starch and Β-Glucan. Int J Food Prop. 2017; 52: 8164. [DOI:10.1080/10942912.2017.1397692]
24. Sayar GH, Mesut C. Psychobiotics: The Potential Therapeutic Promise of Microbes in Psychiatry. Klinik Psikofarmakol Bülteni. 2016; 26(2): 93-102. [DOI:10.5455/bcp.20160531111208]
25. Collins SM, Surette M, Bercik P. The Interplay Between the Intestinal Microbiota and the Brain. Nat Rev Microbiol. 2012; 10(11): 735-42. [DOI:10.1038/nrmicro2876] [PMID]
26. Cong X, Henderson WA, Graf J, McGrath, JM. Early Life Experience and Gut Microbiome: The Brain-Gut-Microbiota Signaling System; Advances in Neonatal Care. J Natio Assoc Neonatal Nurs. 2015; 15: 314. [DOI:10.1097/ANC.0000000000000191] [PMID] [PMCID]
27. Collins SM, Bercik, P. Gut Microbiota: Intestinal Bacteria Influence Brain Activity in Healthy Humans. Nat Rev Gastro Hepat. 2013; 10: 326-327. [DOI:10.1038/nrgastro.2013.76] [PMID]
28. Pract HN. Microbiota in Neuropsychiatry. Herbal and Nutritional Supplements. 2017; 31(4): 270-273. [DOI:10.1097/HNP.0000000000000223] [PMID]
29. Vilarrubias CB. Oh My Gut: Role of Gut Bacteria in Production of Neurochemical Compounds Influencing Mood and Behaviour in Humans. Clara Bullich Vilarrubias. 2015.
30. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F. The Microbiome-Gut-Brain Axis During Early Life Regulates the Hippocampal Serotonergic System in a Sex-Dependent Manner. Mol Psychiatry. 2013; 18: 666-73. [DOI:10.1038/mp.2012.77] [PMID]
31. Evengård B, Schacterle RS, Komaroff AL. Chronic Fatigue Syndrome: New Insights and Old Ignorance. J Intern Med. 1999; 246(5): 455-469. [DOI:10.1046/j.1365-2796.1999.00513.x] [PMID]
32. Lydiard RB, Falsetti SA. Experience with Anxiety and Depression Treatment Studies: Implications for Designing Irritable Bowel Syndrome Clinical Trials. Am J Med . 1999; 107(5A): 65-73. [DOI:10.1016/S0002-9343(99)00082-0]
33. Tiequn B, Guanqun C, Shuo Z. Therapeutic Effects of Lactobacillus in Treating Irritable Bowel Syndrome: A Metaanalysis. Inter Med. 2015; 54(3):243-9. [DOI:10.2169/internalmedicine.54.2710] [PMID]
34. Logan AC, Wong C. Chronic Fatigue Syndrome: Oxidative Stress and Dietary Modifications. Altern Med Rev. 2001; 6(5): 450-9.
35. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM. A Randomized, Double-Blind, Placebo-Controlled Pilot Study of A Probiotic in Emotional Symptoms of Chronic Fatigue Syndrome. Gut Pathog. 2009; 1(1). [DOI:10.1186/1757-4749-1-6] [PMID] [PMCID]
36. Landa RJ. Diagnosis of Autism Spectrum Disorders in the First 3 Years of Life. Nat Clin Pract Neurol. 2008; 4(3): 138-47. [DOI:10.1038/ncpneuro0731] [PMID]
37. Reddy BL, Saier MH. Autism and Our Intestinal Microbiota. J Mol Microbiol Biotechnol. 2015; 25(1):51-5. [DOI:10.1159/000375303] [PMID]
38. de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P. Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their Firstdegree Relatives. J Pediatr Gastroenterol Nutr. 2010; 51(4): 418- 24. [DOI:10.1097/MPG.0b013e3181dcc4a5] [PMID]
39. Williams BL, Hornig M, Parekh T, Lipkin WI. Application of Novel PCR- Based Methods for Detection, Quantitation, and Phylogenetic Characterization of Sutterella Species in Intestinal Biopsy Samples From Children With Autism and Gastrointestinal Disturbances. MBio. 2012; 3(1): 261-11. [DOI:10.1128/mBio.00261-11] [PMID] [PMCID]
40. Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML. Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism. J Child Neurol. 2000; 15(7): 429-35. [DOI:10.1177/088307380001500701] [PMID]
41. Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences Between the Gut Microflora of Children With Autistic Spectrum Disorders and That of Healthy Children. J Med Microbiol. 2005; 54(10): 987-91. [DOI:10.1099/jmm.0.46101-0] [PMID]
42. Davie CA. A Review of Parkinson's Disease. Brit Med Bull. 2008; 86 (1): 109-27. [DOI:10.1093/bmb/ldn013] [PMID]
43. Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM. Medical Records Documentation of Constipation Preceding Parkinson Disease: A Case-Control Study. Neurol. 2009; 73(21): 1752-8. [DOI:10.1212/WNL.0b013e3181c34af5] [PMID] [PMCID]
44. Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA. Increased Intestinal Permeability Correlates With Sigmoid Mucosa Alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease. PLOS One. 2011; 6(12): 28032. [DOI:10.1371/journal.pone.0028032] [PMID] [PMCID]
45. Bangsgaard Bendtsen KM, Krych L, Sorensen DB, Pang W, Nielsen DS, Josefsen K. Gut Microbiota Composition is Correlated to Grid Floor Induced Stress and Behavior in the Balb/C Mouse. PLOS One. 2012; 7(10): 46231. [DOI:10.1371/journal.pone.0046231] [PMID] [PMCID]
46. Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ. The Intestinal Microbiome, Probiotics and Prebiotics in Neurogastroenterology. Gut Microbes. 2013; 4(1): 17-27. [DOI:10.4161/gmic.22973] [PMID] [PMCID]
47. Drescher LS, Thiele S, Mensink GB. A New Index to Measure Healthy Food Diversity Better Reflects a Healthy Diet Than Traditional Measures. J Nutr. 2007; 137(3): 647-51. [DOI:10.1093/jn/137.3.647] [PMID]
48. Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linlokken A, Wilson R. Correlation Between the Human Fecal Microbiota and Depression. J Neurogastroenterol Motil. 2014; 26(8): 1155-62. [DOI:10.1111/nmo.12378] [PMID]
49. Katano Y, Fujinami S, Kawakoshi A, Nakazawa H, Oji S, Iino T. Complete Genome Sequence of Oscillibacter Valericigenes. Stand Genomic Sci. 2012; 6(3): 406-14. [DOI:10.4056/sigs.2826118] [PMID] [PMCID]
50. Ortiz JG, Nieves-Natal J, Chavez P. Effects of Valeriana Officinalis Extracts on [3h] Flunitrazepam Binding, Synaptosomal [3h] Gaba Uptake, and Hippocampal [3h] Gaba Release. Neurochem Res. 1999; 24(11): 1373-8. [DOI:10.1023/A:1022576405534] [PMID]
51. Ledochowski M, Sperner-Unterweger B, Fuchs D. Lactose Malabsorption is Associated With Early Signs of Mental Depression in Females: A Preliminary Report. Dig Dis Sci. 1998; 43(11): 2513-7. [DOI:10.1023/A:1026654820461] [PMID]
52. Montalto M, Curigliano V, Santoro L, Vastola M, Cammarota G. Manna, R. Management and Treatment of Lactose Malabsorption. World J Gastroenterol. 2006; 12(2): 187-91. [DOI:10.3748/wjg.v12.i2.187] [PMID] [PMCID]
53. Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D. Fructose Malabsorption is Associated With Decreased Plasma Tryptophan. Scand J Gastroenterol. 2001; 36(4): 367-71. [DOI:10.1080/003655201300051135] [PMID]
54. Taki K, Takayama F, Niwa T. Beneficial Effects of Bifidobacteria in A Gastroresistant Seamless Capsule on Hyperhomocysteinemia in Hemodialysis Patients. J Ren Nutr. 2005; 15(1):77-80. [DOI:10.1053/j.jrn.2004.09.028] [PMID]
55. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the Probiotic Bifidobacterium Infantis in the Maternal Separation Model of Depression. J Neurosci. 2010; 170(4): 1179-88. [DOI:10.1016/j.neuroscience.2010.08.005] [PMID]
56. Perez-Burgos A, Wang B, Mao YK, Mistry B, McVey Neufeld KA, Bienenstock J. Psychoactive Bacteria Lactobacillus Rhamnosus (JB-1) Elicits Rapid Frequency Facilitation in Vagal Afferents. Am J Physiol Gastrointest Liver Physiol. 2013; 304(2): G211-20. [DOI:10.1152/ajpgi.00128.2012] [PMID]
57. Madsen KL. Interactions Between Microbes and the Gut Epithelium. J Clin Gastroenterol. 2011; 45(Suppl.): 111-4. [DOI:10.1097/MCG.0b013e3182274249] [PMID]
58. Meijerink M, Mercenier A, Wells JM. Challenges in Translational Research on Probiotic Lactobacilli: From In Vitro Assays to Clinical Trials. Benef Microbes. 2013; 4(1):83-100. [DOI:10.3920/BM2012.0035] [PMID]
59. Larsen CN, Nielsen S, Kaestel P, Brockmann E, Bennedsen M, Christensen HR. Dose-Response Study of Probiotic Bacteria Bifidobacterium Animalis Subsp Lactis Bb-12 and Lactobacillus Paracasei Subsp Paracasei Crl-341 in Healthy Young Adults. Eur J Clin Nutr. 2006; 60(11): 1284-93. [DOI:10.1038/sj.ejcn.1602450] [PMID]
60. Collins SM, Kassam, Z Bercik P. The Adoptive Transfer of Behavioral Phenotype Via the Intestinal Microbiota: Experimental Evidence and Clinical Implications. Curr Opin Microbiol. 2013; 16(3): 240-5. [DOI:10.1016/j.mib.2013.06.004] [PMID]
61. Li YT, Cai HF, Wang ZH, Xu J, Fang JY. Systematic Review with Meta-Analysis: Long-Term Outcomes of Faecal Microbiota Transplantation for Clostridium Difficile Infection. Aliment Pharm Ther. 2016; 43(4): 445-57. [DOI:10.1111/apt.13492] [PMID]
62. Bourlioux P. Workgroup of the French Academy of Pharmacy. Faecal Microbiota Transplantation: Key Points to Consider. Ann Pharm Fr. 2015; 73(3): 163-8. [DOI:10.1016/j.pharma.2015.02.001] [PMID]
63. Altay F, Karbancioglu-Guler F, Daskaya-Dikmen C. Heperkan DA. A Review on Traditional Turkish Fermented Nonalcoholic Beverages: Microbiota, Fermentation Process and Quality Characteristics. Int J Food Microbiol. 2013; 167(1): 44-56. [DOI:10.1016/j.ijfoodmicro.2013.06.016] [PMID]
64. Homayouni A, Akbarzadeh F, Vaghef-Mehrabani E. Which Are More Important: Prebiotics or Probiotics? Nutr. 2012; 28(11-12): 1196-7. [DOI:10.1016/j.nut.2012.03.017] [PMID]
65. Lowry CA, Hollis JH, de Vries A, Pan B, Brunet LR, Hunt JR, Paton JF, van Kampen E, Knight DM, Evans AK, Rook GA, Lightman SL. Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience. 2007; 146:756-772. [DOI:10.1016/j.neuroscience.2007.01.067] [PMID] [PMCID]
66. Shell E. Artificial Sweeteners Get a Gut Check. Sci Am. 2015; 312(4): 32-34. [DOI:10.1038/scientificamerican0415-32]
67. Rattray FP, O'Connell MJ. Fermented Milks Kefir. In: Fukay JW, ed. Encyclopedia of Dairy Sciences. 2th ed. San Diego: Academic Press; 2011; 518-524. [DOI:10.1016/B978-0-12-374407-4.00188-6]
68. Rodrigues KL, Caputo LR, Carvalho JC, Evangelista J, Schneedorf JM. Antimicrobial and Healing Activity of Kefir and Kefiran Extract. Int J Antimicrob Agents. 2005; 25(5): 404-8. [DOI:10.1016/j.ijantimicag.2004.09.020] [PMID]
69. Guven A, Guven A, Gulmez M. The Effect of Kefir on the Activities of GSH-Px, GST, CAT, GSH and LPO Levels in Carbon Tetrachloride-iInduced mMice Tissues. J Vet Med B Infect Dis Vet. 2003; 50(8): 412-6. [DOI:10.1046/j.1439-0450.2003.00693.x]
70. Soleimani B, Khomeiri M, Sadeghi A. Fermentation of Camel Milk Using Industrial Starter Culture and Isolates From Chal and Study of Product Changes During Storage Time. Gorgan: Gorgan University of Agricultural Sciences and Natural Resources, M.C. Faculty of Food Sciences and Technology; 2017 [in Persian].
71. Pouramini N, Khomeiri M, Khodaiyan F, Mohamaddifar M, Maghsoudlou Y. Study of Lowering Effect of Prebiotic in Probiotic Media Culture and Their Effect o Probiotic Yogurt Properties. Gorgan: Gorgan University of Agricultural Sciences and Natural Resources, M.C. Faculty of Food Sciences and Technology; 2000 [in Persian].
72. Medrano M, Racedo SM, Rolny IS, Abraham AG, Perez PF. Oral Administration of Kefiran Induces Changes in the Balance of Immune Cells in A Murine Model. J Agric Food Chem. 2011; 59(10): 5299-304. [DOI:10.1021/jf1049968] [PMID]
73. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus Strain Regulates Emotional Behavior and Central Gaba Receptor Expression in A Mouse Via The Vagus Nerve. Proc Natl Acad Sci USA. 2011; 108(38): 16050-16055. [DOI:10.1073/pnas.1102999108] [PMID] [PMCID]
74. Yam BZ, Khomeiri M, Mahounak AS, Jafari SM. Isolation and Identification of Yeasts and Lactic Acid Bacteria from Local Traditional Fermented Camel Milk, Chal. J Food Proc Technol. 2015; 6: 460.
75. Yolmeh M, Khomeiri M, Ahmadi Z. Application of Mixture Design to Introduce an Optimum Cell-Free Supernatant of Multiple-Strain Mixture (MSM) For Lactobacillus Against Food-Borne Pathogens. LWT - Food Sci Tech. 2017; 83: 298-304. [DOI:10.1016/j.lwt.2017.05.035]
76. Ahmadi M, Khomeiri M, Khosroshahi A, Kashaninejad M. Isolation and Identification of Lactic Flora of Traditional Lighvan Cheese. 2000. Eighth National Congress [in Persian].
77. Shoori S, Khomeiri M, Maghsoudlou Y, Sadeghi A. Evaluation of Probiotic and Antagonistic Properties of Some Lactic Acid Bacteria Isolated From Lighvan Cheese and Chal. Gorgan University of Agricultural Sciences and Natural Resources, M.C. Faculty of Food Sciences and Technology; 2012 [in Persian].
78. Khomeiri M, Mortazavi A, Ghodousi B, Khamesan A, Derakhshan A, Shahidi F. Identification of Bifidobacterium Isolated Fecial Samples in Iran Using PCR With Specific Genus Primers and 16SRRNA Sequence Analysis. J Keramn Uni Med Sci. 2004; 12(1):21-31.
79. Su Oh N, Joung JY, Lee JY, Younghoon K. Probiotic and Anti-Inflammatory Potential of Lactobacillus Rhamnosus 4b15 and Lactobacillus Gasseri 4m13 Isolated From Infant Feces. PLOS One. 2018; 13(2): e0192021. [DOI:10.1371/journal.pone.0192021] [PMID] [PMCID]
80. Klopper KB, Deane SM, Dicks LMT. Aciduric Strains of Lactobacillus Reuteri and Lactobacillus Rhamnosus, Isolated From Human Feces, Have Strong Adhesion and Aggregation Properties. Probiotics and Antimicrob Proteins. 2018; 10(1): 89-97. [DOI:10.1007/s12602-017-9307-5] [PMID]
81. Gheziel C, Russo P, Arena MP, Spano G, Ouzari HI, Kheroua O, et al. Evaluation the Probiotic Potential of Lactobacillus Plantarum Strains From Algerian Infant Feces: Toward the Design of Probiotic Starter Cultures Tailored for Developing Countries. Probiotics Antimicrob Proteins. 2018; 1-11. [DOI:10.1007/s12602-018-9396-9] [PMID]
82. Martin R, Miquel S, Benevides L, Bridonnrau C, Robert V, Hudault S, et al. Functional characterization of Novel Faecalibacterium Prausnitzii Strains Isolated From Healthy Volunteers: a Step Forward in the Use of f. Prausnitzii as a Next Generation Probiotic. Front Microbiol. 2017; 8: 1226. [DOI:10.3389/fmicb.2017.01226] [PMID] [PMCID]
83. Rezaei R, Khomeiri M, Aalami M, Kashaninejad M. Effect of Arabic Gum and Guar Gum on Viability of Lactobacillus Acidophilus (LA5) and Bifidobacterium Lactis (Bb12) in Frozen Probiotic Yogurt. Iran Food Sci Tech J. 2015; 8(4).
84. Rezaei R, Khomeiri M, Kashaninejad M. Production of Synbiotic Frozen Soy-Yogurt and Evaluation of its Isoflavone Transformation. Gorgan University of Agricultural Sciences and Natural Resources, PhD. Faculty of Food Sciences and Technology. 2012.
85. Chen KI, Erh MH, Su NW, Liu WH, Chou CC, Cheng KC. Soy Foods and Soybean Products: From Traditional Use to Modern Application. Appl Microbiol Biotechnol. 2012; 96:9-22. [DOI:10.1007/s00253-012-4330-7] [PMID]
86. Ahmadi Z, Khomeiri M, Sadeghi A, Maghsoudlou Y. Iaolation and Identification of Dominant Microflora of Fermented Olive and its Usage in Production of Processed Olive. Gorgan University of Agricultural Sciences and Natural Resources, MSc. Faculty of Food Sciences and Technology. 2015.
87. Nagatsu T, Nagatsu I. Tyrosine Hydroxylase (TH), its Cofactor Tetrahydrobiopterin (BH4), Other Catecholamine-Related Enzymes, and Their Human Genes in Relation to the Drug and Gene Therapies of Parkinson's Disease (PD): Historical Overview and Future Prospects. J Neural Transm. 2016; 123. [DOI:10.1007/s00702-016-1596-4] [PMID]

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.